Positive Trial Data on Evolut TAVR Likely to Support MDT Stock

March 15, 2025

Medical technology company Medtronic plc (MDT) is expected to receive a boost in its stock performance following positive trial data on its Evolut TAVR system. The SMART Trial, a two-year study, showed superior valve performance for the Evolut TAVR system in patients with a small annulus. This promising data indicates the potential for increased adoption of the Evolut TAVR system, leading to improved revenue for Medtronic plc. Investors are recommended to consider buying Medtronic plc's stocks to take advantage of this positive development in the company's product portfolio. For a more accurate prediction of the movement of Medtronic plc's stocks, it is advised to consult the professionals at Stocks Prognosis.

Find out how the MEDTRONIC PLC rate is expected to change

Get Forecast for MDT

Investor opinions & comments:

As an investor, I'm always looking for companies that show promising trial data. Medtronic's Evolut TAVR system seems to have great potential, and I can see it driving their stock price higher in the future

— from MadisonReyes at 03-18-2025 07:05

I've been following Medtronic for a while now, and this positive trial data on the Evolut TAVR system is a clear indication of their commitment to innovation and improving patient outcomes. It definitely makes me more interested in investing in their stocks

— from MatthewGarcia at 03-18-2025 07:04

I'm curious to learn more about the SMART Trial and how the Evolut TAVR system performed in patients with a small annulus. It sounds like this could be a game-changer in the field of medical technology

— from VictoriaGreen at 03-18-2025 06:30

The positive trial data on the Evolut TAVR system is a game-changer for Medtronic. It demonstrates their ability to develop innovative and effective medical technologies, which will likely lead to increased revenue and stock performance

— from WealthyWendy at 03-18-2025 01:43

I'm thrilled to see Medtronic receiving positive trial results for their Evolut TAVR system. This could be a major breakthrough for patients with a small annulus, and I believe it will generate significant interest and revenue for the company

— from LucasPrice at 03-17-2025 13:58

I've been considering investing in the medical technology sector, and Medtronic's positive trial data on the Evolut TAVR system has caught my attention. It seems like a promising investment opportunity with potential for significant growth

— from MarketMikayla at 03-17-2025 10:59

This positive trial data is a major win for Medtronic! It proves the effectiveness of their Evolut TAVR system and sets them apart in the medical technology industry. I wouldn't be surprised if their stock experiences a significant boost

— from MoneyMiles at 03-17-2025 01:32

This is great news for Medtronic! I'm excited to see how the Evolut TAVR system will impact their revenue and overall stock performance

— from CashCathy at 03-16-2025 22:22

This positive trial data is exactly what Medtronic needed to boost their stock performance. It's clear that their investment in the Evolut TAVR system is paying off, and I'm confident that investors will take notice and drive the stock price up

— from AnnaDuncan at 03-16-2025 17:41

Medtronic's Evolut TAVR system has proven its superiority in the SMART Trial, and that's great news for investors. This positive data will likely attract more attention to the company and contribute to the growth of their stock

— from WyattRiley at 03-16-2025 11:33

This positive trial data on the Evolut TAVR system is a clear indication of Medtronic's strength in the medical technology market. I have confidence in their ability to capitalize on this success and deliver strong stock performance

— from PennyParker at 03-16-2025 03:45

The positive trial data on Medtronic's Evolut TAVR system is a testament to their commitment to improving patient outcomes. This will definitely give their stock a boost and attract more investors who recognize the potential in their innovative medical technologies

— from CashClaire at 03-16-2025 01:19

I'm skeptical about the potential for increased adoption of the Evolut TAVR system. With so many competitors in the market, it's difficult to determine if this system will truly stand out and generate substantial revenue for Medtronic

— from AndrewRobinson at 03-15-2025 23:22

I'm impressed with Medtronic's Evolut TAVR system and its performance in the SMART Trial. This positive data could be a major catalyst for the company's stock, as it demonstrates their ability to deliver innovative and effective medical solutions

— from PenelopeWest at 03-15-2025 22:07

I'm not convinced that this positive trial data will have a significant impact on Medtronic's stock performance. There are many other factors at play in the market, and it's hard to predict how investors will react to this news

— from InvestorTom at 03-15-2025 07:42

While the data looks promising, it's important to remember that trial results don't always directly translate into success in the market. I'd like to see more real-world evidence and hear from physicians who have used the Evolut TAVR system before making any investment decisions

— from WealthyWendy at 03-15-2025 06:50

If you want to leave a comment, then you need Login or Register

Other news for MDT

May 22, 2025QuantWave Successfully Achieves Price Target Forecast for MEDTRONIC PLC, Generating 4.54% Profit ~1 min.

QuantWave, the automated forecasting platform, has successfully reached its price target forecast for the stock MEDTRONIC PLC, resulting in a profit of 4.54%....

May 19, 2025QuantWave Hits Bullseye with MEDTRONIC PLC Forecast, Investors Reap 4.93% Profit ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with remarkable accuracy....

May 1, 2025Medtronic Receives FDA Approval for Groundbreaking Defibrillation Lead ~2 min.

Medtronic PLC, a global leader in medical technology, has recently received FDA approval for its revolutionary 4.7F defibrillation lead, the smallest-diameter lumenless lead available on the market....

March 22, 2025Innovative Medical Device Company, Medtronic PLC, Surges in Popularity Among Investors ~2 min.

Medtronic PLC (MDT) is gaining significant attention from investors due to its groundbreaking medical technology and long-term growth potential....

March 21, 2025Medtronic plc MDT: Experts Recommend Buying Stocks for Long-Term Investment ~1 min.

According to the renowned financial experts at Stocks Prognosis, Medtronic plc (MDT) is one of the best European stocks to buy for long-term investment....

Related news

January 24, 2025Trust Co. of Vermont Adds Roper Technologies Inc. to their Stock Portfolio ~2 min.

Trust Co. of Vermont recently disclosed that they now own a substantial stock position in Roper Technologies Inc. (NYSE:ROP). The company has added 565,000 shares of Roper Technologies Inc....

March 20, 2025Callan Family Office LLC Acquires New Position in Roper Technologies Inc. NYSE:ROP ~1 min.

Roper Technologies Inc., a leading technology company, recently saw an increase in investments as Callan Family Office LLC acquired a new position in the company's stock....

March 14, 2025Micron Technology Inc. Attracts Investor Attention: Here's What You Should Know ~2 min.

Micron Technology Inc. (NASDAQ: MU) is currently gaining significant attention from investors....

January 14, 2025ROP: ESCO Technologies vs. Roper Technologies: Which Industrial Tech Stock Holds More Promise ~1 min.

Roper Technologies, Inc. (NYSE:ROP) has been a leader in the industrial tech sector, but now faces competition from ESCO Technologies....

January 1, 202510 Best Dividend Growth Stocks to Buy and Hold in 2025 - Roper Technologies Inc. ~2 min.

Roper Technologies Inc. (ROP), a leading diversified technology company, has emerged as one of the top choices for investors looking for dividend growth stocks to buy and hold in 2025....

Search on StockPrognosis.com

Sections of the site

Positive Trial Data on Evolut TAVR Likely to Support MDT Stock

Find out how the MEDTRONIC PLC rate is expected to change

Investor opinions & comments:

Other news for MDT

Related news

Stocks-Prognosis.com © 2025